news
Yale School of Medicine – Dr. Roy S. Herbst honored at Friends of Cancer Research 25th Anniversary Dinner
/yale-school-of-medicine-dr-roy-s-herbst-honored-at-friends-of-cancer-research-25th-anniversary-dinner
news
OncLive – Superagonists Pull IL-15 Into Focus in Oncology Care
/onclive-superagonists-pull-il-15-into-focus-in-oncology-care
news
Oncology Times – Promises & Challenges of Multi-Cancer Early Detection Screening
/oncology-times-promises-challenges-of-multi-cancer-early-detection-screening
news
Bloomberg Law – Lawmakers Seek to Boost FDA Power Over Fast-Tracked Drugs (1)
/bloomberg-law-lawmakers-seek-to-boost-fda-power-over-fast-tracked-drugs-1
news
Pink Sheet – ctDNA Can Be Used For Patient Selection and Enrichment, But Not As Early Efficacy Endpoint, US FDA Says
/pink-sheet-ctdna-can-be-used-for-patient-selection-and-enrichment-but-not-as-early-efficacy-endpoint-us-fda-says
news
BioCentury – FDA backs use of ctDNA in cancer drug development
/biocentury-fda-backs-use-of-ctdna-in-cancer-drug-development
news
The Cancer Letter – Oncologists, advocates, FDA call for an end to MTD and the “more is better” era in cancer drug dosing
/the-cancer-letter-oncologists-advocates-fda-call-for-an-end-to-mtd-and-the-more-is-better-era-in-cancer-drug-dosing
news
Business Wire – ImmunityBio Announces First Participants Have Been Enrolled in Lung-MAP Trial Studying Anktiva to Activate NK and T Cells in Non-Small Cell Lung Cancer
/business-wire-immunitybio-announces-first-participants-have-been-enrolled-in-lung-map-trial-studying-anktiva-to-activate-nk-and-t-cells-in-non-small-cell-lung-cancer
